Back to Search

BBIO

BridgeBio Pharma, Inc. Common Stock
Data: 2026-11-12
$78.17
Price
-1.23%
Change
$93.42
52W High
$62.50
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Nov 12, 2026

30.1

AI Score

EXTENDED

0.61

Volume Ratio

TBA

Next Earnings

19

+ve Days (30d)

11

-ve Days (30d)

BBIO Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

BBIO Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

BBIO Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Daily Out of Money Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Daily In the Money Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

BBIO Most Active Options by Volume(near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
BBIO Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BBIO Stock Summary

Last updated Nov 12, 2026

BBIO is currently trading at $78.17, positioned above its 200-day moving average of $72.7, indicating a long-term uptrend. The stock has a 52-week range of $62.5 to $93.415.

Technical Analysis: The 50-day moving average stands at $69.93, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 64.7, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.064, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BBIO at 30.1/100 with a EXTENDED recommendation.

BBIO (BridgeBio Pharma, Inc. Common Stock) Indicators

Last updated Nov 12, 2026

Indicator Value
RSI(14) 64.7
CMF (20) 0.064
ROC (10) 10.519
ADX (14) 37.215
Indicator Value
MACD (12,26,9) 2.577
AROONOSC (14) 100.0
WILLAMS %R (14) -20.455
MFI (14) 76.1

BBIO Candlestick Patterns

No validated candlestick patterns fired for BBIO in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

BridgeBio Pharma, Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.

BBIO Moving Averages Analysis

BridgeBio Pharma, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Nov 12, 2026

BridgeBio Pharma, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Nov 12, 2026

BBIO (BridgeBio Pharma, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Nov 12, 2026

Days MA
10 76.51
20 72.52
30 70.3
50 69.93
100 75.15
200 72.7

BBIO Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 15.5 billion
Earnings/Share ($) -3.07
Net Profit Margin (%) -0.5984
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.4935
EPS Estimate Next Year ($) -0.2733
WallStreet Target Price ($) 106.85
Most Recent Quarter

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.